HCRT and major depressive disorder: In addition, patients with major depressive disorder exhibit elevated CSF orexin levels and reduced orexin level amplitude across the 24 h day compared to control participants [44] and as such, antagonising the orexin signal could be beneficial for those patients experiencing sleep disturbance.